Cardiovascular Disease

>

Latest News

COVID-19 Linked to Long-Term Risk of MACE, Especially Among Adults with non-O Blood Types
COVID-19 Linked to Long-Term Risk of MACE, Especially Among Adults with non-O Blood Types

October 9th 2024

Prior SARS-CoV-2 infection was associated with a 2-fold increased risk for MACE for up to 3 years, even among people with no history of CVD, in a new analysis of UK Biobank data.

Progression of Subclinical Atherosclerosis Independently Predicts All-Cause Mortality / image credit - plaque: ©Tefi/stock.adobe.com
Progression of Subclinical Atherosclerosis Independently Predicts All-Cause Mortality

October 2nd 2024

Recent Recreational Drug Use Ups Risk of Repeat Serious CV Event: Daily Dose / image credit: ©New Africa/AdobeStock
Recent Recreational Drug Use Ups Risk of Repeat Serious CV Event: Daily Dose

September 18th 2024

Statin Plus Ezetimibe Outperforms High-Dose Statins in LDL-C Reduction: Daily Dose / image credit: ©New Africa/AdobeStock
Statin Plus Ezetimibe Outperforms High-Dose Statins in LDL-C Reduction: Daily Dose

September 12th 2024

Finerenone Improves Outcomes in Patients with Heart Failure and Mildly Reduced or Preserved Ejection Fraction / Image credit: ©tashatuvango/AdobeStock
Finerenone Improves Outcomes in Patients with Heart Failure and Mildly Reduced or Preserved Ejection Fraction

September 4th 2024

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.